Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:

  • As of Sept. 30, 2014, Ulys has $42.01M in assets under management (AUM). Assets under management grew from a total value of $0 to $42.01M.
  • Independent of market fluctuations, Ulys was a net seller by $0 worth of stocks in the most recent quarter.

Ulys portfolio companies for September 2014 quarter

Ticker Name Portfolio Weight Share Count Price Last Trade
LXRX Lexicon Pharmaceuticals 99.97 29782609 1.41 0.92
Ceres 0.03 31131 0.42 0.00

Past 13F-HR SEC Filings for Ulys

View All Filings for Ulys